Verona Pharma Share Discussion Threads

[joeblogg2] 13/1/2020 12:25

Demand from across the pond will be huge as they understand valuations of biotechs!!

[seanlander] 13/1/2020 12:24

My thoughts too... big spread

[ak62] 13/1/2020 12:21

revving up for a take off

[seanlander] 13/1/2020 12:17

Dropping sales in from an hour ago...cheeky

[seanlander] 13/1/2020 12:14

Mms are struggling to hold this back, even though buys are registering as sells... I know this is happening as I've been buying...

[ak62] 13/1/2020 12:12

£1.25 finish :-)

[aimshares] 13/1/2020 12:08

https://www.proactiveinvestors.co.uk/companies/amp/news/910422

[aimshares] 13/1/2020 12:05

£1.25

[ak62] 13/1/2020 11:54

Thanks sean

it be very interesting afternoon, expecting strong finish

[joeblogg2] 13/1/2020 11:43

Aim what does that equate to uk price up now 67%? thks

[joeblogg2] 13/1/2020 11:41

agree sean. we were at this level before the news some weeks ago and NY closed around this price without the news someone mentioned earlier!! Have picked up a few more.

[seanlander] 13/1/2020 11:38

Looking quiet but I'm watching this closely...

[aimshares] 13/1/2020 11:35

Pre market in USA up 81%https://www.nasdaq.com/market-activity/stocks/vrna/pre-market

[seanlander] 13/1/2020 11:34

Likely to break out with the momentum of the yanks binging later today...

[seanlander] 13/1/2020 11:33

Being held back waiting for the USA to wake up...

[bonzo] 13/1/2020 11:17

Sadly the market's response to good news rarely appears rational. However this will come good in time. Topped up just in time last week!

[ak62] 13/1/2020 11:14

Was expecting to be well over £1-1.10 tbh
wonder why this is being held back ??

[ak62] 13/1/2020 10:31

Loads of buy's are showing in sell column

this will fly

[ohisay] 13/1/2020 10:12

Investors missing there is still plenty of cash in the company ? - 40m£ at the end of September.

[ak62] 13/1/2020 10:05

Topped up bit more @ 85p

[aimshares] 13/1/2020 09:41

Conference Call today 2.00 in the Afternoon Verona Pharma will host an investment community conference call today (Monday, January 13, 2020) at 6.00 am PST / 9.00 am EST / 2.00 pm GMT to discuss the Phase 2b study data. Analysts and investors may participate in the conference call using the conference ID: 2874368 and dialing the following numbers: -- 866 940 4574 for callers in the United States -- 0800 028 8438 for callers in the United Kingdom -- 0800 181 5287 for callers in Germany

[joeblogg2] 13/1/2020 08:55

May be when us opens as they value biotechs!!!

[ih_116147] 13/1/2020 08:23

Next MONSTER opp is DNL ...

The most underpriced and attractive british biotech company with MASSIVE upside potential .Still think this sleeping giant has 10+ bagger upside potential and 2020 could be the year for DNL with all the approvals and partnerships expected during the year .GL



Diurnal Group(DNL)
Market Cap £24 M
Price: 29p


DCF valuation of 202p per share


Investment summary:Alkindi, a cortisol replacement therapy designed for children under 18 years of age, is DNL’s first product on the market. It is expected to be followed by Chronocort for adults – a larger market – which now has a clear pathway for regulatory approval in both Europe and the US. Despite this, the share price is still languishing well below valuations determined by peer group and DCF (202p) analyses

Presentation
hxxps://www.diurnal.co.uk/media/36783/full-year-results-presentationyear-ended-30-june-2019-pp-v2.pdf


Upcoming Catalysts:

US-NDA acceptance for Alkindi in Februry 2020

MAA-Acceptance for Chronocort in February/March 2020

Alkindi approval in Israel expected in 1Q 2020

Alkindi approval in Australien expected in 2Q 2020

US-Partnership for Alkindi & Chronocort expected in 1H 2020

Alkindi & Chronocort Partnership for Asia für Japan und China

US-Approval for Alkindi expected in 4Q 2020

EU Approval for Chronocort expected in 4Q/1Q 2020/21


$88m market opportunity (Europe and US) for Paediatric AI (inc CAH)
$351m market opportunity (Europe and US) for Congenital Adrenal Hyperplasia
$2,767m market opportunity (Europe and US) for Adrenal Insufficiency



Ceo bought another 25k shares at 30p
hxxps://www.ii.co.uk/news/director-dealings-rnsLSE20191216114654_14350421

[ak62] 13/1/2020 08:06

100% Coming up

[aimshares] 13/1/2020 07:49

My guess £2.00 to £2.50 on close of day